BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32881478)

  • 41. EdU Incorporation To Assess Cell Proliferation and Drug Susceptibility in Naegleria fowleri.
    Troth EV; Kyle DE
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0001721. PubMed ID: 33846135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The immune response to Naegleria fowleri amebae and pathogenesis of infection.
    Marciano-Cabral F; Cabral GA
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):243-59. PubMed ID: 17894804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary amebic meningoencephalitis due to Naegleria fowleri: an autopsy case in Japan.
    Sugita Y; Fujii T; Hayashi I; Aoki T; Yokoyama T; Morimatsu M; Fukuma T; Takamiya Y
    Pathol Int; 1999 May; 49(5):468-70. PubMed ID: 10417693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
    Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Silico Structural Analysis of Serine Carboxypeptidase
    Madero-Ayala PA; Mares-Alejandre RE; Ramos-Ibarra MA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293059
    [No Abstract]   [Full Text] [Related]  

  • 46. A Fluorometric Assay for the
    Arberas-Jiménez I; Rizo-Liendo A; Sifaoui I; Chao-Pellicer J; Piñero JE; Lorenzo-Morales J
    Microbiol Spectr; 2022 Aug; 10(4):e0051522. PubMed ID: 35862997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism.
    Kemble SK; Lynfield R; DeVries AS; Drehner DM; Pomputius WF; Beach MJ; Visvesvara GS; da Silva AJ; Hill VR; Yoder JS; Xiao L; Smith KE; Danila R
    Clin Infect Dis; 2012 Mar; 54(6):805-9. PubMed ID: 22238170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Naegleria fowleri strains isolated from human cases of primary amoebic meningoencephalitis in Mexico.
    Cervantes-Sandoval I; de Serrano-Luna JJ; Tapia-Malagón JL; Pacheco-Yépez J; Silva-Olivares A; Galindo-Gómez S; Tsutsumi V; Shibayama M
    Rev Invest Clin; 2007; 59(5):342-7. PubMed ID: 18268889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of differential protein recognition pattern between Naegleria fowleri and Naegleria lovaniensis.
    Gutiérrez-Sánchez M; Carrasco-Yepez MM; Herrera-Díaz J; Rojas-Hernández S
    Parasite Immunol; 2020 Jun; 42(6):e12715. PubMed ID: 32191816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Newborn with Brain-Eating Ameba Infection.
    Celik Y; Arslankoylu AE
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33381798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naegleria fowleri: Diagnosis, Pathophysiology of Brain Inflammation, and Antimicrobial Treatments.
    Pugh JJ; Levy RA
    ACS Chem Neurosci; 2016 Sep; 7(9):1178-9. PubMed ID: 27525348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flucofuron as a Promising Therapeutic Agent against Brain-Eating Amoeba.
    Chao-Pellicer J; Arberas-Jiménez I; Sifaoui I; Piñero JE; Lorenzo-Morales J
    ACS Infect Dis; 2024 Jun; 10(6):2063-2073. PubMed ID: 38757533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclolauranes as plausible chemical scaffold against Naegleria fowleri.
    Arberas-Jiménez I; García-Davis S; Rizo-Liendo A; Sifaoui I; Morales EQ; Piñero JE; Lorenzo-Morales J; Díaz-Marrero AR; Fernández JJ
    Biomed Pharmacother; 2022 May; 149():112816. PubMed ID: 35286966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring the Anti-Infective Value of Inuloxin A Isolated from
    Zeouk I; Sifaoui I; Rizo-Liendo A; Arberas-Jiménez I; Reyes-Batlle M; L Bazzocchi I; Bekhti K; E Piñero J; Jiménez IA; Lorenzo-Morales J
    ACS Chem Neurosci; 2021 Jan; 12(1):195-202. PubMed ID: 33296597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary amebic meningoencephalitis: a case report and literature review.
    Lopez C; Budge P; Chen J; Bilyeu S; Mirza A; Custodio H; Irazuzta J; Visvesvara G; Sullivan KJ
    Pediatr Emerg Care; 2012 Mar; 28(3):272-6. PubMed ID: 22391923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In silico analysis of Naegleria fowleri cathepsin B paralogs: important drug targets.
    Aurongzeb M; Haq SA; Rashid Y; Ahmed Naqvi SH; Hussain SI; Rehman AU; Kaleem I; Bashir S
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3162-3172. PubMed ID: 33928602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effective PCR-based detection of Naegleria fowleri from cultured sample and PAM-developed mouse.
    Kang H; Seong GS; Sohn HJ; Kim JH; Lee SE; Park MY; Lee WJ; Shin HJ
    Eur J Protistol; 2015 Oct; 51(5):401-8. PubMed ID: 26322498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.
    Colon BL; Rice CA; Guy RK; Kyle DE
    J Infect Dis; 2019 Mar; 219(7):1095-1103. PubMed ID: 30358879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of isoflavans of Dalea aurea (Fabaceae) against the opportunistic ameba naegleria fowleri.
    Belofsky G; Carreno R; Goswick SM; John DT
    Planta Med; 2006 Mar; 72(4):383-6. PubMed ID: 16557484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.
    Rice CA; Colon BL; Alp M; Göker H; Boykin DW; Kyle DE
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2037-44. PubMed ID: 25605363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.